Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Ipilimumab × 90 days × Clear all

Sponsor

Conditions

Melanoma 27 Carcinoma, Renal Cell 16 Carcinoma, Non-Small-Cell Lung 15 Neoplasm Metastasis 9 Skin Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Lung Neoplasms 5 Kidney Neoplasms 5 Carcinoma, Hepatocellular 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Urogenital Neoplasms 3 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Penile Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma, Malignant 3 Glioblastoma 3 Uveal Melanoma 2 Ureteral Neoplasms 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroendocrine Tumors 2 Myelodysplastic Syndromes 2

Interventions

Specimen Handling 7 Biopsy 6 fludarabine 3 ruxolitinib 2 decitabine and cedazuridine drug combination 2 Tacrolimus 2 Injections 2 Decitabine 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 venetoclax 1 veliparib 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fludarabine phosphate 1 fedratinib 1 axatilimab 1 Topotecan 1 Thiotepa 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡